ToolGen’s CRISPR loss shows how not to draft a provisional patent

Sources stress the importance of careful drafting after an Australian court rejected the Korean company’s priority claims that were traced back to an unconventional manuscript
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: